# RAMELTEON
> **ANDA212650** · Abbreviated New Drug Application (Generic) · Sponsor: I3 PHARMS · Approved 2020-04-10
## Drug
- **FDA Application Number:** ANDA212650
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RAMELTEON
- **Generic name:** RAMELTEON
- **Active ingredients:** RAMELTEON
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** I3 PHARMS
- **Manufacturer:** TruPharma, LLC
- **First approval:** 2020-04-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212650)
---
*MORVS · CC0 1.0*